RZLVSeptember 23, 2026 at 12:00 PM UTCSoftware & Services

Rezolve AI Targets $60M Cost Savings, Positive EBITDA by Mid-2027

Read source article

What happened

Rezolve AI announced on September 23, 2026, that it expects substantially lower cash burn in the second half of 2026 and an accelerated path to profitability, targeting approximately $60 million in annualized cost savings and positive adjusted EBITDA by the end of H1 2027. The announcement is a forward-looking plan rather than a filed result, continuing management's pattern of providing targets without audited financial detail. The latest deep-value report on the company maintained a WAIT rating due to unproven revenue conversion and heavy cash outflows, citing audited FY2025 revenue of only $46.8 million against a $101.4 million net loss. Since the July 2026 6-K only reaffirmed guidance without interim financials, the market still awaits the first filed 2026 revenue update to validate the hypergrowth narrative. Today's cost-savings announcement does not provide that validation, but it signals management's intent to reduce cash burn and move toward self-funding, which, if executed, could improve the risk profile.

Implication

Investors should treat the cost-savings target as unverified until management discloses the specific actions, timing, and impact on operations. The key near-term catalyst remains the first filed 2026 interim results, due by October 31, 2026 under the master report's checkpoint; if those results show recognized revenue above $150 million through H1 and no dilution, the thesis improves. Conversely, if no filed update appears or ATM usage is disclosed, the bear case strengthens. The announced $60 million in savings could materially reduce cash burn and extend runway, but it may also involve restructuring charges or cuts that hamper growth, so execution risk is high. Given the stock's promotional history and weak governance, we maintain a WAIT and would only consider entry at or below $1.80 per the master report's attractive entry level, or upon confirmation of positive adjusted EBITDA in a filed statement.

Thesis delta

The prior thesis centered on the need for filed 2026 revenue proof by October 31, 2026, with any dilution or missed update being bearish. The new cost-savings announcement is a potential positive but does not alter the core demand for audited financials; it is a management target without independent verification. Accordingly, the WAIT rating and $1.80 attractive entry / $3.20 trim levels remain unchanged, with the main shift being a slightly improved downside if the savings are real and executed without harming growth.

Confidence

Medium